Antihypertensive treatment preceding cerebrovascular diseases is insufficient according to recommendations;Antihypertensiv behandling forud for cerebrovaskulære sygdomme er utilstrækkelig i henhold til rekommandationerne

Ugeskrift for Laeger

Volumn 170, Issue 41, 2008, Pages 3246-3250

  Nielsen, Aneta Aleksandra ^a   Christensen, Cramer ^a   Brandslund, Ivan ^a   Eriksen, Ebbe Wendel ^a   Schmitz, Anita ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; HYPERTENSION; MIDDLE AGED; PRACTICE GUIDELINE; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 54449084729     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Evaluering af apopleksiabehandling i Danmark 1990-2000. Sundhedsstyrelsen. www.cemtv.dk/publikationer/docs/Apopleksi/apopleksi.pdf (april 2008).
2. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000;356:1955-64.
3. HjerneSagen. www.blodpropihjernen.dk (april 2008).
4. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess 2003;7:1-94.
5. Ivey FM, Ryan AS, Hafer-Macko CE et al. High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke. Cerebrovasc Dis 2006;22:368-71. Epub 2006 Aug 3.
6. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-8.
7. STEPwise approach to surveillance. WHO. www.who.int/ncd_surveillance/ steps/stroke/en/flyerStroke2.pdf (april 2008).
8. World Health Organization, International Statistical Classification of Disease and Related Health Problems, 10th Revision Version for 2003, Copyright WHO 1994/2003.
9. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
10. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003;26:Supplement 80-2.
11. Hypertensionsselskab. Hypertensio Arterialis Behandlingsvejledning 2004. www.hypertension.suite.dk/2005/Behandlingsvejledning2004.pdf (april 2008).
12. Diabetesforeningen i Danmark: www.diabetes.dk (april 2008).
13. Khattar RS, Swales JD, Banfield A et al. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous ambulatory blood pressure monitoring in essential hypertension. Circulation 1999;100:1071-6.
14. Ohkubo T, Hozawa A, Nagai K et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000;18:847-54.
15. Letter: About the 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. www.uib.no/isf/letter (13. juni 2005).
16. Hogstrom B. Compliance - efterlevelse, men af hvad? Månedsskr Prakt Lægegern 2006;84:417-23.